Testing effectiveness (Phase 2)Active Not RecruitingNCT06268015What this trial is testingBotensilimab and Balstilimab Optimization in Colorectal CancerWho this might be right forColorectal Cancer Nicholas DeVito, MD 16
Testing effectiveness (Phase 2)UnknownNCT03142282What this trial is testingConsolidative Radiotherapy Plus Maintenance Chemotherapy for Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal CancerRadiotherapy Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 200
Testing effectiveness (Phase 2)Study completedNCT02350530What this trial is testingFOLFOXIRI With or Without Bevacizumab as First-line Treatment for Unresectable Liver-only Metastatic Colorectal Cancer Patients With RAS Mutation-typeWho this might be right forMetastatic Colorectal Cancer Sun Yat-sen University 138
Testing effectiveness (Phase 2)Looking for participantsNCT06051695What this trial is testingEvaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionWho this might be right forSolid Tumor, AdultColorectal CancerNSCLC+17 more A2 Biotherapeutics Inc. 474
Early research (Phase 1)Study completedNCT00084721What this trial is testingIrinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal CancerWho this might be right forColorectal CancerDiarrhea Roswell Park Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT02316028What this trial is testingPhase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC)Who this might be right forLiver MetastasisColorectal Cancer Universitair Ziekenhuis Brussel 11
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Looking for participantsNCT05985954What this trial is testingOpen-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed TherapyWho this might be right forMetastatic Colorectal Cancer M.D. Anderson Cancer Center 27
Large-scale testing (Phase 3)UnknownNCT01910610What this trial is testingMulti-Line Therapy Trial in Unresectable Metastatic Colorectal CancerWho this might be right forColorectal Cancer Metastatic GERCOR - Multidisciplinary Oncology Cooperative Group 464
Early research (Phase 1)Study completedNCT00667641What this trial is testingPaclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+6 more University of Medicine and Dentistry of New Jersey 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07752875What this trial is testingLG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C MutationWho this might be right forOvarian CancerSmall Cell Lung CancerNon Small Cell Lung Cancer+7 more LG Chem 250
Testing effectiveness (Phase 2)Study completedNCT02082782What this trial is testingEfficacy of Irreversible Electroporation (IRE) for Central Colorectal Liver MetastasesWho this might be right forColorectal Liver Metastases Amsterdam UMC, location VUmc 51
Testing effectiveness (Phase 2)Ended earlyNCT05092880What this trial is testingRadioembolization in Elderly/ Fragile Patients With mCRCWho this might be right forColorectal Cancer Metastatic UMC Utrecht 18
Testing effectiveness (Phase 2)UnknownNCT02288078What this trial is testingOral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)Who this might be right forRectal Cancer Clinical Research Support Center Kyush 74
Not applicableNot Yet RecruitingNCT07406126What this trial is testingYttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver MetastasesWho this might be right forColorectal Liver Metastases (CRCLM)Unresectable Colorectal Liver Metastases Fernando Gómez Muñoz 30
Not applicableStudy completedNCT02781935What this trial is testingDiffusion-Weighted MRI for Liver MetastasisWho this might be right forColorectal CancerColon Cancer Liver MetastasisMalignant Neoplasm of Rectum Metastatic to Liver European Organisation for Research and Treatment of Cancer - EORTC 233
Not applicableUnknownNCT04870879What this trial is testingColorectal Metastasis and Liver Transplantation With Organs From Deceased DonorsWho this might be right forColorectal Liver MetastasesColorectal AdenocarcinomaUnresectable Malignant Neoplasm Azienda Ospedaliera di Padova 18
Not applicableEnded earlyNCT00896467What this trial is testingPsychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial TherapyWho this might be right forAnal CancerAnxiety DisorderBreast Cancer+9 more Centre Oscar Lambret 200
Testing effectiveness (Phase 2)Looking for participantsNCT03401294What this trial is testingConversion From Unresectable To Resectable Metastatic Colorectal Cancer.Who this might be right forMetastatic Colorectal Cancer University of Saskatchewan 32
Early research (Phase 1)Active Not RecruitingNCT06464692What this trial is testingStudy to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Adizutecan (ABBV-400) Moves Through the Body of Adult Participants With Unresectable Locally Advanced/Metastatic Colorectal CancerWho this might be right forColorectal Cancer AbbVie 31